Company Overview and News

1
Apple supplier shares slide after Trump tells tech giant to make products in U.S.

2018-09-10 reuters
TAIPEI (Reuters) - Shares of Apple Inc (AAPL.O) suppliers fell across Asia on Monday after U.S. President Donald Trump tweeted that the tech giant should make products in the United States if it wanted to avoid tariffs on Chinese imports.
HHPG HHPD JNNDF AAPL 6740 JPDYY

1
Apple supplier shares slide after Trump tells tech giant to make products in US

2018-09-10 channelnewsasia
Shares of Apple Inc suppliers fell across Asia on Monday after U.S. President Donald Trump tweeted that the tech giant should make products in the United States if it wanted to avoid tariffs on Chinese imports.
HHPG HHPD JNNDF AAPL 6740 JPDYY

5
INCJ raked in ¥769.4 billion in nine years, 2.4 times more than amount it invested

2018-09-01 japantimes.co.jp
Innovation Network Corp. of Japan (INCJ) has said that the government-backed investment fund collected ¥769.4 billion in the nine years from its 2009 launch to the end of March this year, 2.4 times more than the amount it invested.
6501 JNNDF 6740 JPDYY SNE SNEJF HTHIY

6
Panasonic joins effort to license out low-cost OLED panel-making process

2018-08-23 channelnewsasia
Panasonic Corp said on Thursday it has partnered an affiliate of Japan Display Inc to license out a low-cost organic light-emitting diode (OLED) panel-making process, a possible alternative to the conventional method used by dominant South Korean manufacturers.
PCRFY JNNDF AAPL BC94 6740 SMSN JPDYY SNE SNEJF SMSD

 
Japan Display, Inc. ADR 2018 Q1 - Results - Earnings Call Slides

2018-08-10 seekingalpha
The following slide deck was published by Japan Display, Inc. ADR in conjunction with their 2018 Q1 earnings call.
JNNDF 6740 JPDYY

1
Japan Display's Q1 loss narrows on automotive panel sales, cost cuts

2018-08-08 reuters
TOKYO (Reuters) - Japan Display Inc (6740.T) reported on Wednesday a narrower loss for April-June, helped by strong sales of automotive displays and by cost cuts.
JNNDF AAPL 6740 JPDYY

 
Asia markets: US-China trade, earnings and currencies in focus

2018-08-07 cnbc
Asian stocks were set to trade sideways at the open on Wednesday, with trade concerns in the background and after Wall Street gained on the back of strong corporate results.
JNNDF 6740 JPDYY

 
Asian stocks mixed as traders keep tabs on China-US trade row

2018-08-01 channelnewsasia
HONG KONG: Asian markets were mixed on Wednesday (Aug 1), with Shanghai and Hong Kong sharply lower following reports the US was planning to more than double planned tariffs on China.
JNNDF 6740 JPDYY

 
Japan Display plans foray into consumer markets with smart motorcycle helmets and mirrors

2018-08-01 japantimes.co.jp
Japan Display Inc. said Wednesday it will expand its business portfolio by launching new products for consumers, aiming to maximize the advantage of its technologies while gaining new sources of revenue.
JNNDF 6740 JPDYY

 
Flash - Most Asian markets up on hopes of China-US trade talks - France 24

2018-08-01 france24
Most Asian markets rose Wednesday on hopes China and the US will resume talks to resolve a deepening trade war, while oil prices held losses after Donald Trump's offer for Iran talks.
JNNDF 6740 JPDYY

 
Most Asian markets up on hopes of China-US trade talks

2018-08-01 malaymail
HONG KONG, Aug 1 — Most Asian markets rose this morning on hopes China and the US will resume talks to resolve a deepening trade war, while oil prices held losses after Donald Trump’s offer for Iran talks.
JNNDF 6740 JPDYY

1
UPDATE 1-Sharp's Q1 operating profit soars 45 pct on core display unit's strength

2018-07-31 reuters
TOKYO, July 31 (Reuters) - Sharp Corp reported on Tuesday a 45 percent rise in first-quarter operating profit, beating analysts’ estimates on soaring profit at its core display business and strong sales of camera modules and sensors.
HHPG HHPD JNNDF AAPL BC94 6740 SMSN JPDYY SMSD

 
Apple May Be Forced Into Staggered Release for New iPhones … Again

2018-07-30 investorplace
Last year was supposed to be a record-shattering iPhone upgrade “super cycle” launch for Apple (NASDAQ:APPL). That didn’t quite happen, and a big part of last fall’s letdown was a staggered release because the iPhone X was delayed. This year was supposed to be different now that TrueDepth camera manufacturing challenges are smoothed out. However, a new report claims that once again, Apple will face a staggered release for its new iPhones.
JNNDF 6740 JPDYY

1
Upcoming budget-friendly iPhone may have thinner bezel than iPhone X

2018-07-28 technology.inquirer.net - 1
The reported budget-friendly, 6.1-inch LCD iPhone may get thinner bezels through a piece of technology called “Full Active LCD” from Japan Display, according to supply-chain outlet Macotakara via 9to5Mac.
JNNDF 6740 JPDYY

5
Automotive display maker JDI bets big on digital dashboards

2018-07-04 bworldonline
FULLY digital screens are replacing speedometers and dials in vehicles, making industry leader Japan Display Inc. (JDI) optimistic about boosting sales to global car makers.
6501 JNNDF BC94 6740 SMSN JPDYY SNE SNEJF HTHIY SMSD

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 471054106